Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
treatment publishing date : 2022 - 05 - 24 save search
Ardelyx Presents Data at DDW 2022 on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
Published: 2022-05-24 (Crawled : 01:00) - biospace.com/
ARDX | $6.43 0.63% 0.62% 5.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
ibsrela treatment tenapanor
European Medicines Agency Grants Orphan Drug Designation to Cornerstone Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Advanced Unresectable Biliary Tract Cancer
Published: 2022-05-24 (Crawled : 15:20) - globenewswire.com
RFL 4 | $1.71 0.0% 4.2K
|
Finance
|
| O: -0.56%
H: 18.64%
C: 0.0%
cpi-613 613 treatment designation drug cancer
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1618 for the Treatment of Phenylketonuria
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
SYBX | $1.9 -0.52% -0.53% 19K
|
Health Technology
|
| O: 4.13%
H: 0.0%
C: -11.11%
synb1618 treatment designation positive phenylketonuria
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
Published: 2022-05-24 (Crawled : 13:20) - biospace.com/
ORMP A | $2.375 1.06% 1.05% 41K
|
Health Technology
|
| O: -0.87%
H: 0.22%
C: -4.4%
treatment patent granted diabetes therapy insulin
For rare disease patients in Mainland China, hope of greater access to treatment
Published: 2022-05-24 (Crawled : 13:20) - clarivate.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.04%
H: 1.53%
C: 1.37%
treatment rare disease
Oramed Granted U.S. Combination Therapy Patent for Oral GLP-1 & Insulin for the Treatment of Diabetes
Published: 2022-05-24 (Crawled : 12:20) - prnewswire.com
ORMP A | $2.375 1.06% 1.05% 41K
|
Health Technology
|
| O: -0.87%
H: 0.22%
C: -4.4%
treatment patent granted diabetes therapy insulin
European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of Recurrence
Published: 2022-05-24 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.8%
H: 0.58%
C: 0.41%
keytruda risk cancer breast cancer
Aerie Pharmaceuticals Announces First Participant Dosed in the Phase 3 Registrational COMET-2 Study of AR-15512 for the Treatment of Dry Eye Disease
Published: 2022-05-24 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: -4.82%
H: 1.71%
C: -7.63%
ar-1551 treatment disease eye phase 3
Global Opisthorchiasis Treatment Market Research Report 2022: Jaundice, Diarrhea, Fever, Splenomegaly, Weight loss, Tachycardia
Published: 2022-05-24 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -2.41%
H: 0.0%
C: -1.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
treatment research report market
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years
Published: 2022-05-24 (Crawled : 11:00) - biospace.com/
ROIV | $10.89 -0.46% -0.46% 2.8M
|
Manufacturing
|
| O: 5.21%
H: 4.82%
C: 1.82%
vtama treatment fda psoriasis tapinarof plague
Cingulate Announces Complete Enrollment in Human Formulation Study of CTx-2103 for the Treatment of Anxiety Disorders
Published: 2022-05-24 (Crawled : 11:00) - globenewswire.com
CING | $0.8787 -2.9% 19K
|
|
| O: 4.13%
H: 0.13%
C: -10.32%
treatment
Municipal Water and Wastewater Treatment Equipment Market Size to Increase by USD 16.02 Billion from 2021 to 2026| Technavio
Published: 2022-05-24 (Crawled : 02:00) - prnewswire.com
XYL | News | $130.67 -0.04% 0.0% 1.1M
|
Producer Manufacturing
|
| O: -2.06%
H: 0.0%
C: 0.0%
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
ECL | News | $220.78 0.51% 0.0% 710K
|
Process Industries
|
| O: -1.08%
H: 0.0%
C: 0.0%
water treatment market
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.